Mirae Asset Global ETFs Holdings
AXSM icon

Mirae Asset Global ETFs Holdings’s Axsome Therapeutics AXSM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,452
Closed -$3.29M – 3182
2026
Q1 		$3.29M Buy
19,452
+420
+2% +$72.5K ﹤0.01% 972
2025
Q4 		$3.48M Buy
19,032
+230
+1% +$32.1K 0.01% 930
2025
Q3 		$2.28M Sell
18,802
-3,381
-15% -$381K ﹤0.01% 1085
2025
Q2 		$2.32M Buy
22,183
+260
+1% +$27.5K ﹤0.01% 1029
2025
Q1 		$2.56M Buy
21,923
+1,002
+5% +$114K 0.01% 1006
2024
Q4 		$1.77M Buy
20,921
+986
+5% +$90.7K ﹤0.01% 1206
2024
Q3 		$1.79M Buy
19,935
+2,038
+11% +$178K ﹤0.01% 1196
2024
Q2 		$1.44M Buy
+17,897
New +$1.33M ﹤0.01% 1247

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AXSM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 19,452 shares — an estimated $3.29M sold.

Mirae Asset Global ETFs Holdings first reported a position in AXSM in Q2 2024 and held it in 8 quarters. The position peaked at $3.48M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 19,452 Axsome Therapeutics shares in Q2 2026, an estimated $3.29M.
  • Mirae Asset Global ETFs Holdings first reported a position in Axsome Therapeutics in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Axsome Therapeutics position peaked at $3.48M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.